Advancing early diagnostics and monitoring for chronic respiratory diseases

We are happy to announce our partnership with AstraZeneca, reflecting our shared dedication to advancing research on respiratory conditions and enhancing the quality of life for individuals with lung diseases.

Discover more about our collaboration in our latest article, where we unveil the integration of ArtiQ.QC into Unify (Evinova). This integration harnesses Artificial Intelligence to facilitate accurate spirometry tests, marking a significant advancement in the digitization of clinical trials and the monitoring of respiratory patients.

Read the full article to gain insights into the challenges we face in improving access to reliable respiratory testing, our innovative approach to clinical trials, and the collaborative spirit that drives our partnership.